Morgan Stanley’s Bionano Genomics, Inc. Warrant BNGOW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-203
| Closed | -$5 | – | 7789 |
|
|
2023
Q2 | $5 | Hold |
203
| – | – | ﹤0.01% | 7624 |
|
|
2023
Q1 | $19 | Hold |
203
| – | – | ﹤0.01% | 7644 |
|
|
2022
Q4 | $20 | Hold |
203
| – | – | ﹤0.01% | 7770 |
|
|
2022
Q3 | $0 | Hold |
203
| – | – | ﹤0.01% | 8009 |
|
|
2022
Q2 | $0 | Hold |
203
| – | – | ﹤0.01% | 8109 |
|
|
2022
Q1 | $0 | Hold |
203
| – | – | ﹤0.01% | 8234 |
|
|
2021
Q4 | $0 | Hold |
203
| – | – | ﹤0.01% | 8214 |
|
|
2021
Q3 | $0 | Hold |
203
| – | – | ﹤0.01% | 8089 |
|
|
2021
Q2 | $1K | Hold |
203
| – | – | ﹤0.01% | 7667 |
|
|
2021
Q1 | $1K | Hold |
203
| – | – | ﹤0.01% | 7408 |
|
|
2020
Q4 | $0 | Hold |
203
| – | – | ﹤0.01% | 7158 |
|
|
2020
Q3 | $0 | Sell |
203
-97
| -32% | -$20 | ﹤0.01% | 6870 |
|
|
2020
Q2 | $0 | Hold |
300
| – | – | ﹤0.01% | 6778 |
|
|
2020
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 6775 |
|
|
2019
Q4 | $0 | Hold |
300
| – | – | ﹤0.01% | 6825 |
|
|
2019
Q3 | $0 | Hold |
300
| – | – | ﹤0.01% | 6818 |
|
|
2019
Q2 | $0 | Hold |
300
| – | – | ﹤0.01% | 6802 |
|
|
2019
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 6762 |
|
|
2018
Q4 | $0 | Hold |
300
| – | – | ﹤0.01% | 6790 |
|
|
2018
Q3 | $1K | Buy |
+300
| New | +$596 | ﹤0.01% | 6671 |
|
Morgan Stanley's BNGOW Position: Q3 2023 in Review
Morgan Stanley sold out of Bionano Genomics, Inc. Warrant (BNGOW) in Q3 2023, closing a stake of 203 shares — an estimated $5 sold.
Morgan Stanley first reported a position in BNGOW in Q3 2018 and held it in 20 quarters. The position peaked at $1K in Q2 2021. 0 funds tracked by Wall St. Rank hold BNGOW as of Q3 2023.
- Morgan Stanley reported no remaining Bionano Genomics, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
- Morgan Stanley sold 203 Bionano Genomics, Inc. Warrant shares in Q3 2023, an estimated $5.
- Morgan Stanley first reported a position in Bionano Genomics, Inc. Warrant in Q3 2018 and held it in 20 quarters.
- Morgan Stanley's Bionano Genomics, Inc. Warrant position peaked at $1K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Bionano Genomics, Inc. Warrant as of Q3 2023.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.